Siemens Healthineers has finalized its deal to purchase radiopharmaceutical company Advanced Accelerator Applications Molecular Imaging from Novartis, the company announced Tuesday.

Siemens Healthineers announced today that it completed the acquisition of Advanced Accelerator Applications Molecular Imaging ...

NMP's product range includes GE HealthCare radiopharmaceuticals, which are essential for imaging in cardiology, oncology, and ...

GE HealthCare to buy remaining 50% stake in Japanese radiopharmaceutical company, Nihon Medi-Physics from Sumitomo Chemical: Chalfont St Giles, UK Monday, December 2, 2024, 14:00 ...

Since 2008, payment for diagnostic radiopharmaceuticals in the hospital outpatient setting has been packaged or bundled into the payment for the underlying imaging exam. Though this practice was ...

Nuclear medicine, a specialized branch of medical science, has been making remarkable strides in oncology. Unlike ...

The recent U.S. FDA approval of GE HealthCare’s first-of-its-kind PET radiopharmaceutical, Flyrcado™ (flurpiridaz F 18 injection), its in-licensing of Phase II FAPI assets and broadening ...

GalliaPharm® is widely used as a high-quality GMP grade generator for Gallium-68, supporting the production of radiopharmaceuticals for positron emission tomography (PET) imaging, particularly in ...

Lantheus is a radiopharmaceutical company that develops ... Lantheus’ products are primarily used in Positron Emission Tomography (PET), PET-computed tomography (PET-CT), Single Photon Emission ...

As part of GE HealthCare, NMP can build on its expertise developing and manufacturing proprietary and in-licensed radiopharmaceuticals used in single photon emission computed tomography (SPECT) and ...